Testosterone Enanthate

Generic Name
Testosterone Enanthate
Brand Names
Delatestryl, Xyosted
Drug Type
Small Molecule
Chemical Formula
C26H40O3
CAS Number
315-37-7
Unique Ingredient Identifier
7Z6522T8N9
Background

Testosterone enanthate is an esterified variant of testosterone that comes as an injectable compound with a slow-release rate. This slow release is achieved by the presence of the enanthate ester functional group attached to the testosterone molecule. This testosterone derivative was first approved on December 24, 1953.
...

Indication

⑴男性性功能低减替代疗法；⑵绝经后女性晚期乳腺癌姑息性治疗；⑶男性青春期发育迟缓。⑷再生障碍性贫血。

Associated Conditions
Congenital Hypogonadotropic Hypogonadism, Hypergonadotropic Hypogonadism, Idiopathic Hypogonadotropic Hypogonadism
Associated Therapies
-
Clinical Trials
Related News

Testosterone Plus Finasteride Treatment After Spinal Cord Injury

First Posted Date
2014-09-25
Last Posted Date
2023-09-29
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
33
Registration Number
NCT02248701
Locations
🇺🇸

North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida, United States

🇺🇸

James A. Haley Veterans' Hospital, Tampa, FL, Tampa, Florida, United States

RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)

First Posted Date
2014-03-18
Last Posted Date
2022-06-27
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
112
Registration Number
NCT02090114
Locations
🇺🇸

Sibley Memorial Hospital, Washington, District of Columbia, United States

🇺🇸

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers

First Posted Date
2013-10-14
Last Posted Date
2017-05-09
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
20
Registration Number
NCT01962454
Locations
🇺🇸

GSK Investigational Site, Durham, North Carolina, United States

The Effects of Long Term Cyclic Testosterone Administration on Muscle Function and Bone in Older Men

Phase 4
Withdrawn
Conditions
Sarcopenia
Interventions
Drug: Placebo
Drug: Testosterone enanthate
First Posted Date
2011-08-16
Last Posted Date
2015-10-02
Lead Sponsor
The University of Texas Medical Branch, Galveston
Registration Number
NCT01417364
Locations
🇺🇸

The University of Texas Medical Branch, Galveston, Galveston, Texas, United States

Optimizing Protein Intake in Older Americans With Mobility Limitations

Phase 3
Completed
Conditions
Mobility Limitation
Interventions
Drug: Testosterone enanthate
First Posted Date
2011-01-12
Last Posted Date
2021-07-29
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
92
Registration Number
NCT01275365
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

The Role of 5-alpha Reductase in Mediating Testosterone Actions

Phase 4
Completed
Conditions
Healthy
Interventions
Drug: Testosterone Enanthate
Drug: Dutasteride
First Posted Date
2007-06-29
Last Posted Date
2010-05-13
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Target Recruit Count
184
Registration Number
NCT00493987
Locations
🇺🇸

Boston University Medical Center, Boston, Massachusetts, United States

5-Alpha Reductase and Anabolic Effects of Testosterone

First Posted Date
2007-05-21
Last Posted Date
2018-10-11
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
60
Registration Number
NCT00475501
Locations
🇺🇸

North Florida/South Georgia Veterans Health System, Gainesville, Florida, United States

Oral Androgens in Man-4: (Short Title: Oral T-4)

First Posted Date
2006-11-14
Last Posted Date
2008-09-22
Lead Sponsor
University of Washington
Target Recruit Count
20
Registration Number
NCT00399165
Locations
🇺🇸

University of Washington, Seattle, Washington, United States

Testosterone and Physical Function in HIV+ Men

First Posted Date
2005-12-01
Last Posted Date
2018-03-09
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
61
Registration Number
NCT00260143
Locations
🇺🇸

Charles R. Drew University, Los Angeles, California, United States

Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency

First Posted Date
2005-09-12
Last Posted Date
2021-04-28
Lead Sponsor
Leonard S. Marks, M.D.
Target Recruit Count
44
Registration Number
NCT00161304
Locations
🇺🇸

Urological Sciences Research Foundation, Culver City, California, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy